Neurocrine Biosciences Inc (NBIX)
115.00
+3.92 +3.53%
NASDAQ
Jan 21, 20:00
USD
View All Key Stats
Key Stats
Income Statement | |
Revenue (TTM) | 1.042B |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (TTM) | 0.93 |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Net Income (TTM) | 93.41M |
Profitability | |
Gross Profit Margin (Quarterly) | 98.96% |
Profit Margin (Quarterly) | -22.28% |
Dividend | |
Dividend Yield (Forward) | Upgrade |
Dividend Yield | 0.00% |
Price and Valuation | |
Market Cap | 10.74B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
PS Ratio | 10.65 |
PE Ratio | 123.68 |
Price to Book Value | 13.36 |
Other | |
Beta (5Y) | Upgrade |
Debt to Equity Ratio | 0.5284 |
Free Cash Flow (Quarterly) | -17.90M |
Return on Equity | Upgrade |
View All NBIX News
News
-
WireHeadlineTime (ET)
-
PR Newswire01/20 16:01
-
MT Newswires01/08 15:57
-
Yahoo01/08 10:15
-
MT Newswires01/08 08:22
-
SA Breaking News01/08 07:52
-
PR Newswire01/08 07:30
-
PR Newswire01/04 16:01
-
SA Breaking News12/31 13:30
-
MT Newswires12/29 08:52
-
MT Newswires12/22 16:38
-
SA Breaking News12/22 16:37
-
Globe Newswire12/22 16:17
-
Yahoo12/21 11:36
-
Yahoo12/21 04:22
-
Yahoo12/11 08:58
-
MT Newswires12/09 08:24
-
Yahoo12/09 07:51
-
MT Newswires12/07 07:22
-
Yahoo11/19 09:00
-
PR Newswire11/19 08:00
View All Events
Events
Date | Type | Description |
---|---|---|
02/04/2021 | Earnings | Neurocrine Biosciences Inc Fourth Quarter Earnings for 2020 Release |
02/04/2021 16:30 EST | Misc | Neurocrine Biosciences Inc Fourth Quarter Earnings Conference Call for 2020 |
11/09/2020 | Earnings | Neurocrine Biosciences Inc Third Quarter Earnings Result for 2020 |
11/09/2020 16:30 EST | Misc | Neurocrine Biosciences Inc Third Quarter Earnings Conference Call for 2020 |
08/03/2020 16:30 EDT | Misc | Neurocrine Biosciences Inc Second Quarter Earnings Conference Call for 2020 |
08/03/2020 | Earnings | Neurocrine Biosciences Inc Second Quarter Earnings Result for 2020 |
05/19/2020 | Misc | Neurocrine Biosciences Inc Annual General Meeting for 2019 |
05/06/2020 16:30 EDT | Misc | Neurocrine Biosciences Inc First Quarter Earnings Conference Call for 2020 |
05/06/2020 | Earnings | Neurocrine Biosciences Inc First Quarter Earnings Result for 2020 |
02/07/2020 | Misc | Neurocrine Biosciences Inc Annual Report for 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.neurocrine.com
- Investor Relations URL: http://phoenix.corporate-ir.net/phoenix.zhtml?c=68817&p=irol-news&nyo=0
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Mid Cap/Growth
- Next Earnings Release: Feb. 04, 2021
- Last Earnings Release: Nov. 09, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Dec. 29, 1995
- Description: Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.
Analyst Coverage
Consensus Recommendations | |
Buy Recommendations | Upgrade |
Outperform Recommendations | Upgrade |
Hold Recommendations | Upgrade |
Underperform Recommendations | Upgrade |
Sell Recommendations | Upgrade |
Consensus Recommendation | Upgrade |
Consensus Rating | Upgrade |
Target Price | |
Price | 115.00 |
Price Target | Upgrade |
Price Target Upside (Daily) | Upgrade |
Top Fund Holders
Symbol | Name | Weighting |
---|---|---|
FBT | First Trust NYSE Arca Biotech ETF | 3.31% |
DYN1628 | Dynamic Power American Growth Series IP (USD) | 2.98% |
FIJYX | Fidelity Advisor® Biotechnology Z | 2.70% |
BBP | Virtus LifeSci Biotech Products ETF | 2.26% |
BBH | VanEck Vectors Biotech ETF | 2.10% |
ETCHX | Eventide Healthcare & Life Sciences C | 1.98% |
JFNSX | Janus Henderson Global Life Sciences S | 1.73% |
GTMRX | Goldman Sachs Small/Mid Cap Growth R | 1.54% |
XBI | SPDR® S&P Biotech ETF | 1.02% |
FBIOX | Fidelity® Select Biotechnology | 0.99% |
IBB | iShares Nasdaq Biotechnology ETF | 0.79% |
LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.35% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NBIX Tweets Stocktwits
Advertisement